Sustained elevated levels of C-reactive protein and ferritin in pulmonary tuberculosis patients remaining culture positive upon treatment initiation

BACKGROUND: Clinical trials that evaluate new anti-tubercular drugs and treatment regimens take years to complete due to the slow clearance of Mycobacterium tuberculosis infection and the lack of early biomarkers that predict treatment outcomes. Host Inflammation markers have been associated with tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Miranda, Pryscila, Gil-Santana, Leonardo, Oliveira, Marina G., Mesquita, Eliene D. D., Silva, Elisangela, Rauwerdink, Anneloek, Cobelens, Frank, Oliveira, Martha M., Andrade, Bruno B., Kritski, Afrânio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383283/
https://www.ncbi.nlm.nih.gov/pubmed/28384354
http://dx.doi.org/10.1371/journal.pone.0175278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383283/
https://www.ncbi.nlm.nih.gov/pubmed/28384354
http://dx.doi.org/10.1371/journal.pone.0175278

Ejemplares similares